晚期肝病中的免疫功能障碍与感染风险
综述指出肝硬化及酒精相关肝炎等晚期肝病中微生物感染风险增加,感染可诱发新发或进一步失代偿及死亡,尤其在慢加急性肝衰竭临床特征患者中。晚期肝病所致的严重免疫功能障碍或「免疫麻痹」与高短期死亡率相关,但机制尚未完全阐明。证据提示这是复杂动态过程,涉及肝细胞及肝内免疫细胞丧失耐受与免疫激活的平衡,以及肠屏障丧失、微生物产物经门静脉易位等。
要点
- 肝硬化及其他晚期肝病中微生物感染风险增加,感染可促发失代偿和死亡。
- 晚期肝病相关严重免疫功能障碍或「免疫麻痹」与高短期死亡率相关。
- 肠屏障丧失、微生物产物经门静脉易位及先天与适应性免疫细胞功能缺陷参与其中。
核心结论
- 晚期肝病中的免疫功能障碍是微生物感染风险的重要机制,本综述识别了潜在治疗干预靶点。
研究设计与样本
- 综述,重点聚焦肝硬化相关免疫功能障碍和酒精相关肝病,因现有数据主要来自这两种情况。
主要发现
- 肝硬化及其他晚期肝病中微生物感染风险增加,感染可促发新发或进一步失代偿和死亡。
- 晚期肝病所致严重免疫功能障碍或「免疫麻痹」与高短期死亡率相关。
- 肝硬化及严重酒精相关肝炎中,肝细胞和肝内免疫细胞丧失平衡正常情境依赖性耐受与免疫激活双重反应的能力。
- 肠屏障丧失伴微生物产物经门静脉易位,最终导致先天和适应性免疫细胞功能缺陷及免疫调节性髓系细胞生成,允许微生物定植和感染。
临床怎么用
- 原文未据此给出推荐。
局限性
- 免疫功能障碍和免疫缺陷的致病机制尚未完全阐明。
- 现有数据主要来自肝硬化和酒精相关肝病两种情况。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The risk of microbial infections is increased in cirrhosis and other forms of advanced liver disease such as alcohol-associated hepatitis. Such infections may precipitate new or further decompensation and death, especially in patients with clinical features of acute-on-chronic liver failure. The severe immune dysfunction or "immune paralysis" caused by advanced liver disease is associated with high short-term mortality. However, the pathogenic mechanisms underlying immune dysfunction and immunodeficiency are incompletely understood. Evidence to date suggests a complex, dynamic process that perturbs the physiological roles of the liver as a master regulator of systemic immunity and protector against noxious effects of exogenous molecules in the portal vein flowing from the gut. Thus, in cirrhosis and severe alcohol-associated hepatitis, the ability of hepatocytes and intrahepatic immune cells to balance normal context-dependent dichotomous responses of tolerance vs immune activation is lost. Contributing factors include loss of the gut barrier with translocation of microbial products through the portal vein, culminating in development of functional defects in innate and adaptive immune cells, and generation of immune-regulatory myeloid cells that permit microbial colonization and infection. This review addresses key evidence supporting the paradigm of immune dysfunction as a risk for microbial infections and identifies potential therapeutic targets for intervention. The primary focus is on cirrhosis-associated immune dysfunction and alcohol-associated liver disease, because the bulk of available data are from these 2 conditions.
引用
- McGettigan B, Hernandez-Tejero M, Malhi H, et al. Immune Dysfunction and Infection Risk in Advanced Liver Disease. Gastroenterology. 2025. PMID: 39927926. doi:10.1053/j.gastro.2024.08.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。